Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKITA inhaled budesonide versus conventional jet nebulizer in children with mild to moderate asthma
2010-023981-27Phase 2Completed
- Sponsor
- Activaero
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of budesonide in asthma (2 arms), sponsored by Activaero. Primary endpoints: Airway tolerability, safety and applicability of nebulized budesonide delivered with AKITA compared with conventional jet nebulizer and Age threshold for tolerability of controlled positive airway pressure/airflow control. Started Jan 2011; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-023981-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023981-27.